Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection.

Baba TW, Liska V, Hofmann-Lehmann R, Vlasak J, Xu W, Ayehunie S, Cavacini LA, Posner MR, Katinger H, Stiegler G, Bernacky BJ, Rizvi TA, Schmidt R, Hill LR, Keeling ME, Lu Y, Wright JE, Chou TC, Ruprecht RM.

Nat Med. 2000 Feb;6(2):200-6.

PMID:
10655110
2.

Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodies.

Ruprecht RM, Hofmann-Lehmann R, Smith-Franklin BA, Rasmussen RA, Liska V, Vlasak J, Xu W, Baba TW, Chenine AL, Cavacini LA, Posner MR, Katinger H, Stiegler G, Bernacky BJ, Rizvi TA, Schmidt R, Hill LR, Keeling ME, Montefiori DC, McClure HM.

Transfus Clin Biol. 2001 Aug;8(4):350-8. Review.

PMID:
11642027
3.

Passive immunization with human neutralizing monoclonal antibodies: correlates of protective immunity against HIV.

Xu W, Hofmann-Lehmann R, McClure HM, Ruprecht RM.

Vaccine. 2002 May 6;20(15):1956-60. Review.

PMID:
11983253
4.

Antibody protection: passive immunization of neonates against oral AIDS virus challenge.

Ruprecht RM, Ferrantelli F, Kitabwalla M, Xu W, McClure HM.

Vaccine. 2003 Jul 28;21(24):3370-3. Review.

PMID:
12850342
5.
6.

Passive immunization as tool to identify protective HIV-1 Env epitopes.

Kramer VG, Siddappa NB, Ruprecht RM.

Curr HIV Res. 2007 Nov;5(6):642-55. Review.

PMID:
18045119
7.

A new approach to AIDS research and prevention: the use of gene-mutated HIV-1/SIV chimeric viruses for anti-HIV-1 live-attenuated vaccines.

Haga T, Kuwata T, Ui M, Igarashi T, Miyazaki Y, Hayami M.

Microbiol Immunol. 1998;42(4):245-51. Review.

8.

The simian immunodeficiency virus infected macaque: a model for pediatric AIDS.

McClure HM, Anderson DC, Ansari AA, Klumpp SA.

Pathol Biol (Paris). 1992 Sep;40(7):694-700. Review.

PMID:
1480404
9.
10.

Towards an HIV-1 vaccine: lessons from studies in macaque models.

Hulskotte EG, Geretti AM, Osterhaus AD.

Vaccine. 1998 May-Jun;16(9-10):904-15. Review.

PMID:
9682336
11.

Antibodies and resistance to natural HIV infection.

Nabel GJ, Sullivan NJ.

N Engl J Med. 2000 Oct 26;343(17):1263-5. Review. No abstract available.

PMID:
11071680
12.

A new look at HIV transmission from seropositive mothers to their infants: the facts beyond serology.

Jehuda-Cohen T.

Isr J Med Sci. 1994 May-Jun;30(5-6):364-8. Review.

PMID:
8034484
13.

The acute HIV infection: implications for intervention, prevention and development of an effective AIDS vaccine.

Nishimura Y, Martin MA.

Curr Opin Virol. 2011 Sep;1(3):204-10. doi: 10.1016/j.coviro.2011.05.007. Review.

14.

Animal models for perinatal transmission of pathogenic viruses.

Ruprecht RM, Fratazzi C, Sharma PL, Greene MF, Penninck D, Wyand M.

Ann N Y Acad Sci. 1993 Oct 29;693:213-28. Review.

PMID:
8267266
15.

Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN).

Tomescu C, Abdulhaqq S, Montaner LJ.

Clin Exp Immunol. 2011 May;164(2):158-69. doi: 10.1111/j.1365-2249.2011.04379.x. Epub 2011 Mar 17. Review.

16.

Targeting early infection to prevent HIV-1 mucosal transmission.

Haase AT.

Nature. 2010 Mar 11;464(7286):217-23. doi: 10.1038/nature08757. Review.

PMID:
20220840
17.

Are anti-HIV IgAs good guys or bad guys?

Zhou M, Ruprecht RM.

Retrovirology. 2014 Dec 14;11:109. doi: 10.1186/s12977-014-0109-5. Review.

18.

The oral mucosa immune environment and oral transmission of HIV/SIV.

Wood LF, Chahroudi A, Chen HL, Jaspan HB, Sodora DL.

Immunol Rev. 2013 Jul;254(1):34-53. doi: 10.1111/imr.12078. Review.

20.

Supplemental Content

Support Center